Next Article in Journal
Roles of MicroRNA across Prenatal and Postnatal Periods
Next Article in Special Issue
A Systematic Evaluation of Blood Serum and Plasma Pre-Analytics for Metabolomics Cohort Studies
Previous Article in Journal
Macromolecular Interactions Control Structural and Thermal Properties of Regenerated Tri-Component Blended Films
Previous Article in Special Issue
Effect of High-Carbohydrate Diet on Plasma Metabolome in Mice with Mitochondrial Respiratory Chain Complex III Deficiency
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(12), 1992;

Advances in Lipidomics for Cancer Biomarkers Discovery

Department of Neurosciences and Imaging, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
Radiation Oncology Unit, SS Annunziata Hospital, 66100 Chieti, Italy
Department of Pharmacy, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
Department of Medical Oral and Biotechnological Sciences, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
Analitical Biochemistry and Proteomics Unit, Research Centre on Aging (Ce.S.I), University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy
Author to whom correspondence should be addressed.
Academic Editor: Ting-Li (Morgan) Han
Received: 29 September 2016 / Revised: 11 November 2016 / Accepted: 22 November 2016 / Published: 28 November 2016
(This article belongs to the Special Issue Metabolomic Technologies in Medicine)
View Full-Text   |   Download PDF [2034 KB, uploaded 28 November 2016]   |  


Lipids play critical functions in cellular survival, proliferation, interaction and death, since they are involved in chemical-energy storage, cellular signaling, cell membranes, and cell–cell interactions. These cellular processes are strongly related to carcinogenesis pathways, particularly to transformation, progression, and metastasis, suggesting the bioactive lipids are mediators of a number of oncogenic processes. The current review gives a synopsis of a lipidomic approach in tumor characterization; we provide an overview on potential lipid biomarkers in the oncology field and on the principal lipidomic methodologies applied. The novel lipidomic biomarkers are reviewed in an effort to underline their role in diagnosis, in prognostic characterization and in prediction of therapeutic outcomes. A lipidomic investigation through mass spectrometry highlights new insights on molecular mechanisms underlying cancer disease. This new understanding will promote clinical applications in drug discovery and personalized therapy. View Full-Text
Keywords: cancer; lipidomics; biomarkers; prognostic factors; diagnostic factors cancer; lipidomics; biomarkers; prognostic factors; diagnostic factors

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Perrotti, F.; Rosa, C.; Cicalini, I.; Sacchetta, P.; Del Boccio, P.; Genovesi, D.; Pieragostino, D. Advances in Lipidomics for Cancer Biomarkers Discovery. Int. J. Mol. Sci. 2016, 17, 1992.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top